Patent AT-E399548-T1: [Translated] PREVENTING THE DEVELOPMENT OF DYSKINESIA
HealthData.Gov
Updated Oct 29, 2026
About this dataset
The present invention relates to the prevention of the development of sensitization caused by chronic use of dopaminergic agents using an alfa2-adrenoceptor antagonist or a pharmaceutically acceptable ester or salt thereof.
Data and resources (1)
- HTML
Official Data Source
Access the complete Patent AT-E399548-T1: [Translated] PREVENTING THE DEVELOPMENT OF DYSKINESIA on the official website.
Modified Apr 29, 2026